semaglutide effects on heart in Patients With Obesity and Failure Across Mildly Reduced or Preserved Ejection Fraction Semaglutide cardiovascular outcomes align more

Track timing and severity so your clinician can see whether the pattern favors: Hypoglycemia Orthostatic hypotension Dehydration A different cause If this keeps happening, your next steps matter, and tracking creates options rather than panic

Tirzepatide arrived more recently, with Mounjaro approved for diabetes in November 2022 and Zepbound receiving weight management approval in May 2025

For example, if you have heart disease, then phentermine is off the table as it is contraindicated in this condition

While Ozempic contains the active GLP-1 ingredient semaglutide, not all GLP-1 drugs are Ozempic

Feelings of fullness may occur earlier during meals, which aligns with the medications intended effect but may require adjustments to eating habits